Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01317147 · ClinicalTrials.gov registry record
The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 12
- Enrollment target
NCT01317147: Completed study, sponsored by University of Pittsburgh.
NCT01317147 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01317147 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The morbidly obese frequently present with mood and anxiety disorders, which are often treated with serotonin reuptake inhibitors (SRI) antidepressant drugs. The investigators hypothesized that gastric bypass surgery would decrease the absorption of SRI. The investigators also wished to determine whether a reduction in SRI levels would increase the likelihood of worsening depressive symptoms.
Interventions
- PROCEDURE Roux-en-Y gastric bypass (RYGBP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
What the finished NCT01317147 record still lists
NCT01317147 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Roux-en-Y gastric bypass (RYGBP) is the first listed.
NCT01317147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01317147 about?
NCT01317147 is a clinical study titled "The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors". The morbidly obese frequently present with mood and anxiety disorders, which are often treated with serotonin reuptake inhibitors (SRI) antidepressant drugs. The investigators hypothesized that gastric bypass surgery would decrease the absorption of SRI. The investigators also wished to determine wh...
What is the current status of trial NCT01317147?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2007-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01317147?
The interventions under investigation include: Roux-en-Y gastric bypass (RYGBP) (PROCEDURE).
Who is sponsoring clinical trial NCT01317147?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia